Welcome to LookChem.com Sign In|Join Free

CAS

  • or
methyl 2-[(ethoxyacetyl)amino]-5-fluorobenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

777096-81-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 777096-81-8 Structure
  • Basic information

    1. Product Name: methyl 2-[(ethoxyacetyl)amino]-5-fluorobenzoate
    2. Synonyms:
    3. CAS NO:777096-81-8
    4. Molecular Formula: C12H14FNO4
    5. Molecular Weight: 255.2423
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 777096-81-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 409.4°C at 760 mmHg
    3. Flash Point: 201.4°C
    4. Appearance: N/A
    5. Density: 1.251g/cm3
    6. Vapor Pressure: 6.51E-07mmHg at 25°C
    7. Refractive Index: 1.532
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: methyl 2-[(ethoxyacetyl)amino]-5-fluorobenzoate(CAS DataBase Reference)
    11. NIST Chemistry Reference: methyl 2-[(ethoxyacetyl)amino]-5-fluorobenzoate(777096-81-8)
    12. EPA Substance Registry System: methyl 2-[(ethoxyacetyl)amino]-5-fluorobenzoate(777096-81-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 777096-81-8(Hazardous Substances Data)

777096-81-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 777096-81-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,7,0,9 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 777096-81:
(8*7)+(7*7)+(6*7)+(5*0)+(4*9)+(3*6)+(2*8)+(1*1)=218
218 % 10 = 8
So 777096-81-8 is a valid CAS Registry Number.

777096-81-8Downstream Products

777096-81-8Relevant articles and documents

Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2

Freeman, George A.,Andrews III, C. Webster,Hopkins, Andrew L.,Lowell, Gina S.,Schaller, Lee T.,Cowan, Jill R.,Gonzales, Stephen S.,Koszalka, George W.,Hazen, Richard J.,Boone, Lawrence R.,Ferris, Rob G.,Creech, Katrina L.,Roberts, Grace B.,Short, Steven A.,Weaver, Kurt,Reynolds, David J.,Milton, John,Ren, Jingshan,Stuart, David I.,Stammers, David K.,Chan, Joseph H.

, p. 5923 - 5936 (2007/10/03)

HIV-1 nonnucleoside reverse transcriptase Inhibitors (NNRTIs) are part of the combination therapy currently used to treat HIV infection. The features of a new NNRTI drug for HIV treatment must include selective potent activity against both wild-type virus as well as against mutant virus that have been selected by use of current antiretroviral treatment regimens. Based on analogy with known HIV-1 NNRTI inhibitors and modeling studies utilizing the X-ray crystal structure of inhibitors bound in the HIV-1 RT, a series of substituted 2-quinolones was synthesized and evaluated as HIV-1 inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 777096-81-8